18 March 2015

Phenotypic Approaches in Drug Discovery

Organised by:

SCI's Fine Chemicals Group

SCI, London, UK

Registration Closed

This event is no longer available for registration.

Synopsis

Recent reports have suggested that target-based approaches are useful but not informative enough and limit understanding the full pharmacology of drug actions. Some have suggested that phenotypic screening is a more successful approach to discovering novel drugs. Therefore, it is no surprise that phenotypic screening is making a comeback in drug discovery. This meeting will introduce the uses of phenotypic screening and systems pharmacology and will provide practical insights into some of the recent changes in its use and cover the benefits and issues in this area from a range of talks including case studies.

Attendees

This meeting is targeted at all those who are involved in target selection and hit identification in drug discovery and those interested in furthering their knowledge of current and emerging approaches to these areas.

Programme

Day 1

09:30: Registration and refreshments
09:55: Welcome and introduction
10:00: The cellular uptake of pharmaceutical drugs is carrier-mediated and thus a problem not of biophysics but of systems biology
Professor Douglas Kell, University of Manchester
10:45: Novel macrolide inspired macrocycles, the rule breakers for “Hard Targets”, identified by phenotypic screening
Dr Mihailo Banjanac, Fidelta
11:20: Phenotypic screening using human primary cell based assays
Dr Jeroen DeGroot, BioFocus
12:00: Lunch and exhibition
13:15: Zebrafish phenotypic screens for anti-inflammatory (or pro-resolution) drug discovery
Professor Steve Renshaw, University of Sheffield
13:50: Phenotype in Agrochemical Discovery
Dr Anthony Flemming, Syngenta
1430: A chemogenomic approach to elucidating a mechanism for directing stem cell differentiation
Dr Robert Owen, Pfizer
15:00: Refreshment break
15:20: In silico approaches to support mode-of-action analysis using chemical and biological data
Dr Andreas Bender, University of Cambridge
15:50: Chemical Proteomics: a multifaceted tool in drug discovery
Dr Andreas Bender, University of Cambridge
16:20: Integrating phenotypic screens with in vivo imaging and reverse phase protein array technologies to advance translation
Dr Neil Carragher, Edinburgh Cancer Research Centre
17:10: Closing remarks
17:20: Wine reception

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

SCI

14/15 Belgrave Square
London SW1X 8PS

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees

Early Bird Fees - before 6 February 2015

SCI Member	GB£100
SCI Student Member	GB£35
SCI Subsidised Member	GB£65
Non-Member	GB£135

Standard Fees - after 6 February 2015

SCI Member	GB£120
SCI Student Member	GB£45
SCI Subsidised Member	GB£80
Non-Member	GB£165

Become an SCI Member and save on this and future events

See Membership Options

Booking Process/Deadlines

Booking terms and conditions